The influence of rapidly controlling hyperglycemia with insulin pump on ?-cell function of newly diagnosed type 2 diabetic patients
Kun YANG; Kunquan GUO.
Chinese Journal of Diabetes
; (12)2000.
Artículo en Zh | WPRIM | ID: wpr-587968
Documentos relacionados
The influence of rapidly controlling hyperglycemia with insulin pump on β-cell function of newly diagnosed type 2 diabetic patients
Closed-Loop Therapy and Preservation of C-Peptide Secretion in Type 1 Diabetes.
Postprandial glycemia and insulin secretion following glutamine administration: A randomized controlled trial.
Evaluation of hypoglycemic therapeutics and nutritional supplementation for type 2 diabetes mellitus management: An insight on molecular approaches.
Association of Hepcidin levels in Type 2 Diabetes Mellitus treated with metformin or combined anti-diabetic agents in Pakistani population.
Trial of Hybrid Closed-Loop Control in Young Children with Type 1 Diabetes.
Effectiveness and safety of basal insulin therapy in type 2 diabetes mellitus patients with or without metformin observed in a national cohort in China.
A safety and pharmacodynamics study of temelimab, an antipathogenic human endogenous retrovirus type W envelope monoclonal antibody, in patients with type 1 diabetes.
Teplizumab and ß-Cell Function in Newly Diagnosed Type 1 Diabetes.
Golimumab and Beta-Cell Function in Youth with New-Onset Type 1 Diabetes.